Myomo, Inc. financial data

Symbol
MYO on NYSE
Industry
Orthopedic, Prosthetic & Surgical Appliances & Supplies
Location
137 Portland Street, 4 Th Floor, Boston, MA
State of incorporation
DE
Fiscal year end
December 31
Latest financial report
10-Q - Q3 2024 - Nov 6, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 242 % -16%
Quick Ratio 41.6 % +26.7%
Debt-to-equity 63.7 % +23.9%
Return On Equity -86.3 % +1.57%
Return On Assets -52.7 % +8.96%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 30.2M shares +14.1%
Common Stock, Shares, Outstanding 30.2M shares +14.1%
Entity Public Float 9.53M USD -4.83%
Common Stock, Value, Issued 3.03K USD +14.1%
Weighted Average Number of Shares Outstanding, Basic 38M shares +7.61%
Weighted Average Number of Shares Outstanding, Diluted 38M shares +7.61%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 25.2M USD +36.2%
Cost of Revenue 7.56M USD +30.2%
Research and Development Expense 4.09M USD +81.1%
Selling and Marketing Expense 3.4M USD +42.5%
General and Administrative Expense 3.25M USD +35%
Operating Income (Loss) -8.39M USD -4.71%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -8.03M USD -3.07%
Income Tax Expense (Benefit) 352K USD +468%
Net Income (Loss) Attributable to Parent -8.38M USD -6.73%
Earnings Per Share, Basic -0.23 USD/shares +54%
Earnings Per Share, Diluted -0.23 USD/shares +54%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 6.62M USD -4.18%
Cash, Cash Equivalents, and Short-term Investments 11.1M USD
Accounts Receivable, after Allowance for Credit Loss, Current 3.73M USD +48.2%
Inventory, Net 3.38M USD +128%
Assets, Current 14.7M USD -8.34%
Property, Plant and Equipment, Net 561K USD +226%
Operating Lease, Right-of-Use Asset 467K USD -34.8%
Other Assets, Noncurrent 205K USD +125%
Assets 16.3M USD -4.35%
Liabilities, Current 6.99M USD +21%
Operating Lease, Liability, Noncurrent 29.2K USD -88.5%
Liabilities 7.02M USD +16.4%
Accumulated Other Comprehensive Income (Loss), Net of Tax 396K USD
Retained Earnings (Accumulated Deficit) -103M USD -8.87%
Stockholders' Equity Attributable to Parent 9.29M USD -15.7%
Liabilities and Equity 16.3M USD -4.35%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -3.25M USD -78.7%
Net Cash Provided by (Used in) Financing Activities 5.36M USD -7.11%
Net Cash Provided by (Used in) Investing Activities -3.54M USD -7758%
Common Stock, Shares Authorized 65M shares 0%
Common Stock, Shares, Issued 30.2M shares +14.1%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -1.44M USD -137%
Deferred Tax Assets, Valuation Allowance 14.4M USD -29.6%
Deferred Tax Assets, Gross 14.4M USD -29.6%
Operating Lease, Liability 235K USD -66.9%
Depreciation 29.7K USD -39%
Payments to Acquire Property, Plant, and Equipment 59.8K USD +32.7%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -7.98M USD -1.62%
Lessee, Operating Lease, Liability, to be Paid 247K USD -68.7%
Property, Plant and Equipment, Gross 965K USD +16.6%
Operating Lease, Liability, Current 205K USD -54.9%
Lessee, Operating Lease, Liability, to be Paid, Year Two 0 USD -100%
Lessee, Operating Lease, Liability, to be Paid, Year One 103K USD -82.2%
Operating Lease, Weighted Average Discount Rate, Percent 0.23 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 12.8K USD -84%
Lessee, Operating Lease, Liability, to be Paid, Year Three 0 USD
Deferred Tax Assets, Operating Loss Carryforwards 11.7M USD -34.9%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 10M shares 0%
Lessee, Operating Lease, Liability, to be Paid, Year Four 0 USD
Preferred Stock, Shares Outstanding 0 shares
Deferred Tax Assets, Net of Valuation Allowance 0 USD
Share-based Payment Arrangement, Expense 887K USD -15.9%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%